PFIZER INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pfizer Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Pfizer Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$4.93B, a 78% decline year-over-year.
  • Pfizer Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $26.1B.
  • Pfizer Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$14.8B, a 51.1% decline from 2021.
  • Pfizer Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$9.82B, a 1.73% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $26.1B +$40.9B Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$14.8B -$5.02B -51.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$9.82B -$167M -1.73% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$9.65B -$1.16B -13.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$8.49B +$12B +58.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$20.4B -$7.09B -53.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$13.4B -$4.12B -44.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$9.23B +$1.18B +11.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$10.4B -$222M -2.18% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 -$10.2B +$4.79B +32% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 -$15B +$1.02B +6.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$16B +$4.61B +22.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$20.6B -$9.43B -84.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 -$11.2B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.